EODData

MEMBERSHIP REGISTER LOG IN

FRA, 4AJ0: ALK-ABELLO AS DK -50

22 Jan 2026
LAST:

29.42

CHANGE:
 0.34		OPEN:
29.42		HIGH:
29.42		ASK:
0.00		VOLUME:
91
CHG(%):
1.14		PREV:
29.76		LOW:
29.42		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Jan 2629.4229.4229.4229.4291
21 Jan 2629.7629.7629.7629.7691
20 Jan 2629.4029.4029.4029.4091
19 Jan 2629.4829.4829.4829.4891
16 Jan 2629.6829.6829.6829.6891
15 Jan 2630.5830.5830.5830.5891
14 Jan 2630.2430.2430.2430.2491
13 Jan 2630.1230.1230.1230.1291
12 Jan 2630.7830.7830.7830.7891
09 Jan 2630.5230.5230.5230.52501

PROFILE

Name:ALK-ABELLO AS DK -50
About:ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mites, grass and tree pollen, ragweed, Japanese cedar, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that provide support, guidance, and relief, as well as smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including anaphylaxis. It has a collaboration with Torii Pharmaceutical Co., Ltd. for the development of GRAZAX, a grass pollen allergy tablet; CEDARCURE, a tablet for the treatment of Japanese cedar pollen induced allergy; and MITICURE for the treatment of house dust mite-induced allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Sector:Healthcare
Industry:Biotechnology
Address:Bøge Allé 6-8, Hørsholm, Denmark, 2970
Website:https://www.alk.net
ISIN:DK0061802139
LEI:529900SGCREUZCZ7P020

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:45.01 
PEG Ratio:1.13 
Price to Sales:1.13 
Price to Book:8.07 
Profit Margin:0.18 
Operating Margin:0.28 
Return on Assets:0.12 
Return on Equity:0.20 
Revenue:813.72M 
EBITDA:242.59M 
Shares:201.31M 
Market Cap:5.922B 

TECHNICAL INDICATORS

MA5:29.550.4%
MA10:30.002.0%
MA20:30.152.5%
MA50:30.032.1%
MA100:28.921.7%
MA200:26.2712.0%
STO9:1.45 
STO14:1.45 
RSI14:37.78 
WPR14:-98.55 
MTM14:-0.62
ROC14:-0.02 
ATR:0.32 
Week High:30.583.9%
Week Low:29.400.1%
Month High:30.784.6%
Month Low:29.4012.0%
Year High:31.607.4%
Year Low:17.6067.2%
Volatility:12.15 

RECENT SPLITS

Date Ratio
29 Mar 202220-1
28 Mar 202220-1

RECENT DIVIDENDS

Date Amount
16 Mar 2017$0.00
11 Mar 2016$0.00
13 Mar 2015$0.00
13 Mar 2014$0.00
13 Mar 2013$0.00
28 Mar 2012$0.00
04 Apr 2011$0.00
29 Mar 2010$0.00
30 Mar 2009$0.03